NHS
-
Three COVID treatments gain approval
Regulators today endorse three medicines for treating adults with COVID-19 as part of a clinical and cost-effectiveness review. Read more
-
COVID protection drug rejected
A drug designed to protect vulnerable patients against COVID is unlikely to be effective enough, according to UK regulators. Read more
-
Genetic test recommended to prevent new born babies going deaf
The NHS could adopt a genetic test for new-borns who develop neonatal bacterial infection to reduce the risk of loss of hearing, it has been announced. Read more
-
Concern over switching Parkinson’s drugs
Patients with Parkinson’s disease should be protected against unplanned switching of the brand of drugs they take, campaigners have warned. Read more
-
New indication for cannabis treatments
The NHS is to support a new use of cannabis-derived medicines, it has been announced. Read more
-
Late stage cancer diagnoses affect ethnic minorities most
Women from Caribbean and African backgrounds are up to two times more likely to receive a late stage diagnosis for some cancers than white British women in England, a new study has revealed. Read more
-
NICE calls for more people to be offered statins
More people in England could be offered statins, following newly published draft guidance from NICE. Read more
-
Artificial pancreas approved for type 1 diabetes
A hybrid closed loop system for managing blood glucose levels in type 1 diabetes has been backed by regulators in England. Read more
-
England to get somatrogon for growth hormone deficiency
Children being treated for growth disturbance could be treated with injections weekly instead of daily, according to new guidance. Read more
-
Children at growing risk from winter infections
Scarlet fever bacteria and flu are posing a serious risk to children this winter, parents have been warned. Read more